FGH Biotech, Inc. — Form D/A

FGH Biotech, Inc. of HOUSTON, TX, a company, filed a Form D amendment with the SEC on 2018-05-22. The offering totals $4.0M, of which $2.1M was reported sold. Industry: Pharmaceuticals.

Offering

• Filed: 2018-05-22
• Form: D/A
• Accession: 0001657572-18-000001
• Industry: Pharmaceuticals
• Exemptions: 06b
• Total offering: $4.0M
• Amount sold: $2.1M
• Remaining: $1.9M
• Minimum investment: $13K
• Investors: 18
• Date of first sale: 2017-10-23
• Security types: debt
• Revenue range: Decline to Disclose
• SEC file number: 021-294133

Issuer

• Name: FGH Biotech, Inc.
• CIK: 0001657572
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Incorporated: 2011
• Address: 414 THAMER CIRCLE, HOUSTON, TX, 77024
• Phone: 7134654028

Officers, directors & promoters (6)

Other filings by this issuer (2)

More

• CIK 1657572 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search